drugset / Trial / NCT06317311
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to understand the effectiveness of dostarlimab and carboplatin-paclitaxel followed by dostarlimab monotherapy in participants with endometrial cancer
Timeline
- Start
- 2024-05-07
- Primary completion
- 2026-07-15
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 5 unknown | Intravenous |
| Subject | Dostarlimab | Monoclonal antibody | 1000 mg | Intravenous |
| Subject | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |